|
|
 |
|
Viewing report
|
|
|
|
Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2018
GlobalData, Oct 2011, Pages: 83
Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2018
Summary
GlobalData, the industry analysis specialist, has released its new report, “Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global hepatitis b vaccines market. The report identifies the key trends shaping and driving the global hepatitis b vaccines market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global hepatitis b vaccines sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
GlobalData estimated the global hepatitis b vaccines market at $997.0m in 2010, and forecast it to grow at a compound annual growth rate (CAGR) of 4.1% for the next eight years, to reach $1,376.1m by 2018. During the period 2005–2010, the market grew at a CAGR of 6.7%, from $720.5m to $997.0. The growth is primarily attributed to the increase in the vaccination rate and coverage among different age groups, as a result of government programs and increased public awareness. The market would also be driven by birth population growth and the need for therapeutic vaccines in cases of cirrhosis, liver disease, and primary liver cancer (hepatocellular carcinoma or HCC).
Scope
The report provides information on the key drivers and challenges of the hepatitis b vaccines market. Its scope includes -
- Annualized seven key markets (the US, France, Germany, Italy, Spain, the UK and Japan) hepatitis b vaccines market revenues data from 2005 to 2010, forecast for eight years to 2018.
- Pipeline analysis data providing a split across the different phases, type of vaccines being developed and emerging trends by seven key markets. Pipeline candidates fall under major classes such as single antigen vaccine, combinational vaccine and others.
- Analysis of the current and future competition in the seven key countries hepatitis b vaccines market. Key market players covered are Dynavax Technologies Ltd., Merck, GlaxoSmithKline, Sanofi, GenPhar, LG Life Sciences, Genexine and NanoBio Corp.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the hepatitis b vaccines therapeutics market.
- Analysis of key recent licensing and partnership agreements in hepatitis b vaccines market
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global hepatitis b vaccines market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global hepatitis b vaccines market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global hepatitis b vaccines market landscape? – Identify, understand and capitalize.
Keywords
Pharma, Pharmaceuticals, Healthcare, Deal Value, Deal Volume, Private Equity, Venture Capital, Partnership, Licensing, Agreements, North America, Europe, Asia-Pacific, Rest of the World (ROW), Merger, M&A, Acquisition, Equity Offering, Debt Offering, Capital raising, Asset Purchase, Private Placement, Secondary offering, IPO, Initial Public Offer, cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, women's health, Upfront Payment, Milestone Payment, Phases, Clinical Trials
|
|
|
|
